tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ENFN Stock Latest News

Enfusion price target raised to $13 from $11 at Stifel
The FlyEnfusion price target raised to $13 from $11 at Stifel
3d ago
ENFN
Enfusion, Inc. Reports Strong Q3 2024 Results
PremiumCompany Announcements
Enfusion, Inc. Reports Strong Q3 2024 Results
2M ago
ENFN
Enfusion price target raised to $11 from $10 at Stifel
PremiumThe Fly
Enfusion price target raised to $11 from $10 at Stifel
2M ago
ENFN
Enfusion reports Q3 EPS 5c, consensus 6c
PremiumThe Fly
Enfusion reports Q3 EPS 5c, consensus 6c
2M ago
ENFN
Enfusion narrows FY24 EPS view to $202M-205M, consensus $204.8M
PremiumThe Fly
Enfusion narrows FY24 EPS view to $202M-205M, consensus $204.8M
2M ago
ENFN
ENFN Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsENFN Upcoming Earnings Report: What to Expect?
2M ago
ENFN
Enfusion jumps roughly 11% after report of sale exploration
Premium
The Fly
Enfusion jumps roughly 11% after report of sale exploration
3M ago
ENFN
Enfusion exploring possible sale after receiving takeover interest, Reuters says
Premium
The Fly
Enfusion exploring possible sale after receiving takeover interest, Reuters says
3M ago
ENFN
Enfusion trading resumes
PremiumThe Fly
Enfusion trading resumes
3M ago
ENFN
Enfusion trading halted, volatility trading pause
PremiumThe Fly
Enfusion trading halted, volatility trading pause
3M ago
ENFN
Enfusion exploring options, including possible sale, Reuters reports
PremiumThe Fly
Enfusion exploring options, including possible sale, Reuters reports
3M ago
ENFN
Enfusion reports Q2 EPS 5c, consensus 6c
PremiumThe Fly
Enfusion reports Q2 EPS 5c, consensus 6c
5M ago
ENFN
Warner Bros. upgraded, Cerence downgraded: Wall Street’s top analyst calls
PremiumThe FlyWarner Bros. upgraded, Cerence downgraded: Wall Street’s top analyst calls
8M ago
BAX
MMM
Enfusion assumed with an Overweight at Morgan Stanley
Premium
The Fly
Enfusion assumed with an Overweight at Morgan Stanley
8M ago
ENFN
Enfusion reports Q1 adjusted EPS 6c, consensus 4c
Premium
The Fly
Enfusion reports Q1 adjusted EPS 6c, consensus 4c
8M ago
ENFN
Enfusion to hold an analyst and investor day
PremiumThe Fly
Enfusion to hold an analyst and investor day
9M ago
ENFN
Enfusion’s Upcoming Investor Day and Information Disclosure
PremiumCompany Announcements
Enfusion’s Upcoming Investor Day and Information Disclosure
9M ago
8K
ENFN
Enfusion to hold an analyst and investor day
PremiumThe Fly
Enfusion to hold an analyst and investor day
9M ago
ENFN
Enfusion down 3% at $9.00 after short thesis by Spruce Point Capital
PremiumThe Fly
Enfusion down 3% at $9.00 after short thesis by Spruce Point Capital
9M ago
ENFN
Spruce Point short Enfusion, sees 40%-60% long-term downside risk
PremiumThe FlySpruce Point short Enfusion, sees 40%-60% long-term downside risk
9M ago
ENFN
Spruce Point short Enfusion, sees 40%-60% long-term downside risk
Premium
The Fly
Spruce Point short Enfusion, sees 40%-60% long-term downside risk
9M ago
ENFN
Enfusion price target raised to $9 from $8 at BofA
Premium
The Fly
Enfusion price target raised to $9 from $8 at BofA
9M ago
ENFN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >